{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:28Z","timestamp":1789726288653,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.healun.2004.05.008","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:49:35Z","timestamp":1115747375000},"page":"932-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Renal and Vestibular Toxicity Due to Inhaled Tobramycin in a Lung Transplant Recipient"],"prefix":"10.1016","volume":"24","author":[{"given":"Vivek N.","family":"Ahya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden M.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pochettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Kotloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2004.05.008_bib1","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis","volume":"328","author":"Ramsey","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2004.05.008_bib2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1183\/09031936.95.08091594","article-title":"Inhalation of antibiotics in cystic fibrosis","volume":"8","author":"Touw","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2004.05.008_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2004.05.008_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.healun.2004.05.008_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ppul.1125","article-title":"Efficacy and safety of aerosolized tobramycin in cystic fibrosis","volume":"32","author":"Pai","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.healun.2004.05.008_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005382-200304000-00003","article-title":"Bronchiolitis obliterans syndrome in lung transplant recipients","volume":"18","author":"Choi","year":"2003","journal-title":"J Thorac Imag"},{"issue":"suppl 3","key":"10.1016\/j.healun.2004.05.008_bib7","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.120.3_suppl.114S","article-title":"Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa","volume":"120","author":"Couch","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.healun.2004.05.008_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2004.05.008_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3062.2001.003003128.x","article-title":"Infectious complications of lung transplantation","volume":"3","author":"Alexander","year":"2001","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2004.05.008_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/thorax.58.5.444","article-title":"Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients","volume":"58","author":"Ward","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2004.05.008_bib11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.149.6.7516251","article-title":"Infectious complications of lung transplantation. Impact of cystic fibrosis","volume":"149","author":"Flume","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2004.05.008_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1592\/phco.23.4.543.32122","article-title":"Toxic serum trough concentrations after administration of nebulized tobramycin","volume":"23","author":"Kahler","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"suppl 3","key":"10.1016\/j.healun.2004.05.008_bib13","doi-asserted-by":"crossref","first-page":"94S","DOI":"10.1378\/chest.120.3_suppl.94S","article-title":"Formulation of aerosolized therapeutics","volume":"120","author":"Kuhn","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.healun.2004.05.008_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/AAC.39.1.34","article-title":"Macromolecular mechanisms of sputum inhibition of tobramycin activity","volume":"39","author":"Hunt","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.healun.2004.05.008_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ppul.10185","article-title":"Acute renal failure in cystic fibrosis","volume":"34","author":"Hoffmann","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.healun.2004.05.008_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance","volume":"13","author":"de Groot","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.healun.2004.05.008_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00007691-199904000-00004","article-title":"Tobramycin pharmacokinetics in patients with cystic fibrosis preceding and following lung transplantation","volume":"21","author":"Dupuis","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.healun.2004.05.008_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/00007890-199606150-00009","article-title":"Renal hemodynamics after lung transplantation. A prospective study","volume":"61","author":"Navis","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2004.05.008_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.ASN.0000057542.86377.5A","article-title":"Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use","volume":"14","author":"Smith","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2004.05.008_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1681\/ASN.V1251059","article-title":"Pharmacokinetic interactions augment toxicities of sirolimus\/cyclosporine combinations","volume":"12","author":"Podder","year":"2001","journal-title":"J Am Soc Nephrol"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804002839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804002839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:11:03Z","timestamp":1760947863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249804002839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1053249804002839"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2004.05.008","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal and Vestibular Toxicity Due to Inhaled Tobramycin in a Lung Transplant Recipient","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2004.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}